Eagle Global Advisors’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Eagle Global Advisors’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-6,500	Closed	-$555K	–	222
2019 Q2	$555K	Hold	6,500	–	–	0.02%	164
2019 Q1	$703K	Buy	+6,500	New	+$647K	0.03%	157
2018 Q4	–	Sell	-2,200	Closed	-$216K	–	249
2018 Q3	$216K	Buy	+2,200	New	+$238K	0.01%	220
2018 Q1	–	Sell	-5,500	Closed	-$576K	–	258
2017 Q4	$576K	Hold	5,500	–	–	0.02%	175
2017 Q3	$620K	Hold	5,500	–	–	0.02%	169
2017 Q2	$616K	Buy	+5,500	New	+$621K	0.02%	197
2016 Q3	–	Sell	-2,600	Closed	-$379K	–	390
2016 Q2	$379K	Hold	2,600	–	–	0.01%	230
2016 Q1	$372K	Hold	2,600	–	–	0.01%	239
2015 Q4	$402K	Hold	2,600	–	–	0.01%	234
2015 Q3	$372K	Sell	2,600 -500	-16%	-$69.9K	0.01%	242
2015 Q2	$445K	Hold	3,100	–	–	0.01%	233
2015 Q1	$437K	Hold	3,100	–	–	0.01%	210
2014 Q4	$459K	Hold	3,100	–	–	0.01%	207
2014 Q3	$477K	Hold	3,100	–	–	0.01%	188
2014 Q2	$435K	Buy	+3,100	New	+$344K	0.01%	182

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

CAM

Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return

Eagle Global Advisors's TARO Position: Q3 2019 in Review

Eagle Global Advisors sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q3 2019, closing a stake of 6,500 shares — an estimated $555K sold.

Eagle Global Advisors first reported a position in TARO in Q2 2014 and held it in 15 quarters. The position peaked at $703K in Q1 2019. 101 funds tracked by Wall St. Rank hold TARO as of Q3 2019.

Eagle Global Advisors reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q3 2019 after selling out during the quarter.
Eagle Global Advisors sold 6,500 Taro Pharmaceutical Industries Ltd. shares in Q3 2019, an estimated $555K.
Eagle Global Advisors first reported a position in Taro Pharmaceutical Industries Ltd. in Q2 2014 and held it in 15 quarters.
Eagle Global Advisors's Taro Pharmaceutical Industries Ltd. position peaked at $703K in Q1 2019.
101 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q3 2019.

Based on Eagle Global Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.